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Background
Cardiac imaging has been identified as a potential use of
hybrid PET-MRI. This new technology allows simulta-
neous Positron Emission Tomography (PET) and MR
scanning to occur.
This case study features a 34 year old male with
known pulmonary sarcoidosis which was diagnosed in
2006 and initially treated with immunosuppressants.
He presented with NYHA functional class 2 symp-
toms. ECHO showed asymmetrical LV anterior and
lateral wall hypertrophy with a maximum wall thick-
ness of 18mm in the basal and mid anterior and lateral
wall.
The patient was referred for a cardiac18F Fluorodeox-
yglucose (FDG) PET-MR study to determine the cause
of the hypertrophy. The possible differential diagnoses
included hypertrophic cardiac myopathy with pulmonary
sarcoidosis or cardiac sarcoidosis.
Methods
Prior to the scan, the patient followed a high protein, low
carbohydrate diet for one day. This was then followed by
a 12 hour fast to suppress physiologic glucose metabo-
lism by the heart.
The patient was administered with 355mBq of 18F
FDG 180 minutes prior to the PET-MR study.
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Figure 1 From left to right: 1) SA STIR demonstrating shows homogeneous signal from the LV myocardium. 2) SA LGE demonstrating focal mid
myocardial wall LGE in the antero-septal segments. 3) SA 18F FDG PET showing focal uptake in the antero-septal segements Note is made of a
Reveal device visualsied on images 1 & 2.
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A simultaneous PET-MR study was acquired. A stan-
dard CMR protocol was undertaken in conjunction with
a simultaneous 10 minute single PET bed using a Sie-
mens Biograph mMR hybrid PET-MR scanner. This is a
3T magnet containing a 260mm field of view PET detec-
tor located at the isocentre.
Results
The scan demonstrated mediastinal 18F FDG avid lym-
phadenopathy with anterio-lateral myocardial thickening
with mid-myocardial LGE and focal 18F FDG uptake com-
patible with active myocardial inflammation within an area
of “scar” in keeping with active cardiac sarcoidosis.
The oedema sensitive STIR sequence did not differenti-
ate between the hyper-metabolic active disease and the
chronic “burnt out” disease.
Conclusions
This patient is one of the first examples of imaging active
cardiac sarcoidosis using a hybrid PET-MR technique.
It demonstrates the potential for differentiating between
active and chronic cardiac sarcoidosis during one scan.
This new imaging technique could have a substantial
impact on the diagnosis and management of cardiac
sarcoidosis
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Figure 2 These images show the fusion of the PET onto the STIR sequence, demonstrating the area of active inflammation despite there being
no oedema.
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